Relmada Therapeutics Inc (RLMD)
3.86
-0.05
(-1.28%)
USD |
NASDAQ |
Apr 24, 16:00
3.855
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Shareholders Equity (Quarterly): 85.36M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 85.36M |
| September 30, 2023 | 100.73M |
| June 30, 2023 | 111.34M |
| March 31, 2023 | 125.47M |
| December 31, 2022 | 140.44M |
| September 30, 2022 | 166.34M |
| June 30, 2022 | 196.85M |
| March 31, 2022 | 210.40M |
| December 31, 2021 | 208.26M |
| September 30, 2021 | 72.69M |
| June 30, 2021 | 96.85M |
| March 31, 2021 | 91.15M |
| December 31, 2020 | 105.58M |
| September 30, 2020 | 122.21M |
| June 30, 2020 | 132.23M |
| March 31, 2020 | 113.16M |
| September 30, 2019 | 5.977M |
| June 30, 2019 | 7.613M |
| March 31, 2019 | 0.4739M |
| December 31, 2018 | 1.435M |
| September 30, 2018 | -8.740M |
| June 30, 2018 | -5.513M |
| Date | Value |
|---|---|
| March 31, 2018 | -2.316M |
| December 31, 2017 | 0.7212M |
| September 30, 2017 | 1.465M |
| June 30, 2017 | 1.460M |
| March 31, 2017 | 2.802M |
| December 31, 2016 | 4.675M |
| September 30, 2016 | 5.574M |
| June 30, 2016 | 7.042M |
| March 31, 2016 | 10.20M |
| December 31, 2015 | 11.76M |
| September 30, 2015 | 13.84M |
| June 30, 2015 | 8.810M |
| March 31, 2015 | 2.494M |
| December 31, 2014 | 4.593M |
| September 30, 2014 | -20.72M |
| February 28, 2014 | -0.0312M |
| November 30, 2013 | -0.028M |
| August 31, 2013 | -0.0137M |
| May 31, 2013 | -0.0213M |
| February 28, 2013 | -0.0018M |
| August 31, 2012 | 0.0114M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
5.977M
Minimum
Sep 2019
210.40M
Maximum
Mar 2022
116.26M
Average
112.25M
Median
Shareholders Equity (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 0.607M |
| Lifecore Biomedical Inc | -1.842M |
| Corvus Pharmaceuticals Inc | 38.68M |
| NeuroBo Pharmaceuticals Inc | 16.68M |
| Ensysce Biosciences Inc | -0.3229M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 97.55M |
| Total Liabilities (Quarterly) | 12.19M |